Replies to post #123385 on Biotech Values

[DewDiligence]

Monsanto has had a poor history as an long-term investment…

You must be thinking of a different company. MON was spun off by the drug company, Pharmacia in an IPO at a split-adjusted price of $10/sh in Oct 2000; since then, the share price is up a whopping 645%, which equates to a compounded annual return of about 50%!

Sales and earnings have increased at a similar rate during the past 11 years.

…and I don't see why that would change.

Neither do I.